Practice
Featured experience
Amazon.com $15 billion notes offering
We advised the underwriters on the offering
Circle $1.05 billion IPO
We are advising Circle on its IPO, the first IPO by a stablecoin issuer
Novartis $6 billion notes offering
We advised Novartis on the investment-grade debt offering
SailPoint $1.4 billion IPO
The shares are listed on the Nasdaq Global Select Market
Fifth Third Bancorp $1 billion senior notes offering
The investment-grade notes are due 2028
Fifth Third Bank $1 billion senior notes offering
The investment-grade notes are due 2025
ADT $1.2 billion cash tender offer for stock
The company’s shares are traded on the NYSE
DFZQ $300 million bonds offering
The investment-grade bonds are due 2025
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
RXO $355 million notes offering
The notes are being offering in connection with the intended spinoff of RXO
Denali Therapeutics $316 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Diageo Capital $2 billion notes offering
The investment-grade notes are due 2025, 2027 and 2033
British American Tobacco $600 million notes offering
The investment-grade notes are due 2032
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction